David Xu
Publications by Year
Research Areas
Computational Drug Discovery Methods, Chemical Synthesis and Analysis, Protein Kinase Regulation and GTPase Signaling, Microbial Natural Products and Biosynthesis, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition(2018)271 cited
- → Small-Molecule Covalent Modification of Conserved Cysteine Leads to Allosteric Inhibition of the TEAD⋅Yap Protein-Protein Interaction(2018)202 cited
- → Enzyme intermediates captured “on the fly” by mix-and-inject serial crystallography(2018)166 cited
- → Targeted Therapies for Targeted Populations: Anti-EGFR Treatment for EGFR -Amplified Gastroesophageal Adenocarcinoma(2018)117 cited
- → RIG-I–like receptor LGP2 protects tumor cells from ionizing radiation(2014)89 cited
- → Secreted Protein Acidic and Rich in Cysteine Is a Matrix Scavenger Chaperone(2011)58 cited
- → Small-molecule covalent bond formation at tyrosine creates a binding site and inhibits activation of Ral GTPases(2020)46 cited
- → Expression and pharmacological characterization of a stimulatory subtype of adenosine receptor in fetal chick ventricular myocytes.(1992)38 cited
- → A novel phospholipase C- and cAMP-independent positive inotropic mechanism via a P2 purinoceptor(1997)30 cited
- → Small-molecule Ca V α 1 ⋅Ca V β antagonist suppresses neuronal voltage-gated calcium-channel trafficking(2018)25 cited